Sumitomo Mitsui Trust Holdings, Inc. Adaptive Biotechnologies Corp Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $134 Billion
- Q2 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 6,899,631 shares of ADPT stock, worth $32.1 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,899,631
Previous 6,176,707
11.7%
Holding current value
$32.1 Million
Previous $19.8 Million
25.97%
% of portfolio
0.02%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding ADPT
# of Institutions
187Shares Held
152MCall Options Held
8.4KPut Options Held
56K-
Viking Global Investors LP30MShares$139 Million0.43% of portfolio
-
Rubric Capital Management LP New York, NY14MShares$65.1 Million1.5% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$54.2 Million0.0% of portfolio
-
Matrix Capital Management Company, LP Waltham, MA11.6MShares$53.8 Million0.32% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.4MShares$53.1 Million0.38% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $664M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...